These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 13104885)

  • 21. [Resistance of Mycobacterium tuberculosis to antituberculotics in synthetic culture media].
    BANYASZ T
    Tuberkulozis; 1957; 10(5-6):107-9. PubMed ID: 13496268
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of the size of inoculum on susceptibility testing of Mycobacterium tuberculosis.
    KENNEY M; JOHNSON PM; LOVELOCK FJ
    Am Rev Tuberc; 1955 Sep; 72(3):390-2. PubMed ID: 13249046
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mechanism of action of associated PAS and streptomycin; bacteriological study in vitro].
    KITAMOTO O; RIST N
    Rev Tuberc; 1951; 15(10-11):950-6. PubMed ID: 14912808
    [No Abstract]   [Full Text] [Related]  

  • 24. [Koch bacillus resistance to antibiotics in the inoculated and antibiotic-treated guinea pig].
    LE MELLETIER J; BROWAEYS J; CAULET T
    Ann Biol Clin (Paris); 1955; 13(5-6):305-8. PubMed ID: 13249138
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resistance determination in practice in a tuberculosis clinic].
    ERMISCH K; ERMISCH U
    Zentralbl Bakteriol Orig; 1955 Dec; 164(8):566-76. PubMed ID: 13371902
    [No Abstract]   [Full Text] [Related]  

  • 27. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test.
    DUNBAR FP; DAVIS R; JEFFERIES MB
    Am Rev Tuberc; 1958 Feb; 77(2):350-5. PubMed ID: 13509034
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of results after administration of drugs in the presence of Mycobacterium tuberculosis resistant].
    VICENTE-MASTELLARI A; YOUNG RV
    Arch Med Panamenos; 1956; 5(1):1-7. PubMed ID: 13341547
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sensitivity to antituberculous drugs of bacillary strains from initial tuberculosis in children].
    DEBRE R; FOUSSEREAU S; NOUFFLARD H
    Presse Med (1893); 1956 Oct; 64(78):1791-3. PubMed ID: 13389308
    [No Abstract]   [Full Text] [Related]  

  • 31. Problems of drug resistance.
    MITCHISON DA
    Br Med Bull; 1954; 10(2):115-24. PubMed ID: 13160421
    [No Abstract]   [Full Text] [Related]  

  • 32. [New laboratory accomplishments in thoracic pathology].
    CETRANGOLO A
    Rev Med Cubana; 1956 May; 67(5):418-25. PubMed ID: 13371028
    [No Abstract]   [Full Text] [Related]  

  • 33. RESISTANT tubercle bacilli.
    Lancet; 1957 Apr; 272(6973):825-6. PubMed ID: 13417612
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of anti-tuberculous antibiotics and drugs in vitro; comparative study on streptomycin, PAS, thiosemicarbazone succinci derivative, and isonicotinic acid hydrazide].
    INZERILLO R; CHITI E
    Arch Maragliano Patol Clin; 1952; 7(5):879-901. PubMed ID: 13017839
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro effect of various substances on Mycobacterium tuberculosis. I. Titration of streptomycin, aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid in Dubos medium].
    TERNI M; ZANELLI QUARANTINI MG
    Boll Ist Sieroter Milan; 1951; 30(11-12):689-702. PubMed ID: 14934836
    [No Abstract]   [Full Text] [Related]  

  • 36. [A study on PAS-resistance; its relation to clinical symptoms and SM-resistance, the change of resistance in the course of treatment].
    ITO Y; KONDO H
    Kekkaku; 1955 Nov; 30(11):643-7. PubMed ID: 13286847
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effective tuberculostatic minimal concentration of streptomycin, conteben, PAS and neoteben in vitro and resistance phenomenon].
    WEIDMANN S; SAAME H
    Z Hyg Infektionskr; 1953; 136(6):579-86. PubMed ID: 13103314
    [No Abstract]   [Full Text] [Related]  

  • 38. [Incidence of resistance of Koch bacillus to antibiotics during primary infection].
    BRETON A; GAUDIER B; PIERRET R
    Arch Fr Pediatr; 1956; 13(6):664-74. PubMed ID: 13373449
    [No Abstract]   [Full Text] [Related]  

  • 39. DRUG resistance of tubercle bacilli following antibiotic treatment.
    S Afr Med J; 1952 Jul; 26(29):585. PubMed ID: 12984191
    [No Abstract]   [Full Text] [Related]  

  • 40. [Resistance of the tubercle-bacillus to drugs in general and PAS in particular].
    DE BEULE R
    Schweiz Z Tuberk; 1952; 9(2):76-85. PubMed ID: 14958380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.